A 53-year-old Richmond grandfather underwent heart valve replacement and by-pass surgery at Methodist Sugar Land Hospital last week, becoming the first patient to undergo open heart surgery in Fort Bend County.
Without effective interventions, it is estimated that by the year 2030 around 3.3 million Australians will have developed type 2 diabetes.
Those who most need medical care in Korea but can afford it least spend a greater percentage of their income on health services, according to a Yale School of Medicine study published in the American Journal of Public Health.
Glucocorticoids are widely used as drugs to treat inflammatory conditions such as arthritis or dermatitis and they act in part by suppressing T cell function.
New data reported at the 30th Annual Scientific Sessions of the Society for Cardiovascular Angiography and Interventions, May 9-12, 2007, in Orlando, Fla., will offer clues to the fate of a new-generation drug-eluting stent that is vying for a place in the treatment of coronary artery disease.
Adult bone marrow stem cells may help cure certain genetic eye diseases, according to University of Cincinnati researchers. Scientists have completed a study using mice which showed that bone marrow stem cells can switch roles and produce keratocan, a natural protein involved in the growth of the cornea?the transparent, outer layer of the eyeball.
New scientific evidence is helping to build a compelling case for oncolytic viruses as a first-line and adjunctive treatment for many cancers. Reovirus, a non-pathogenic virus under development at Calgary, Alberta-based Oncolytics Biotech, has shown powerful anti-cancer activity against cultured tumor cells, in animal models, and in human clinical trials. Oncolytics’ proprietary reovirus formulation, Reolysin?, is active against numerous cancers, including intractable sarcomas and melanomas.
Hamilton College researchers have identified molecules that have been shown to be effective in the fight against breast cancer.
Scientists with the Lineberger Comprehensive Cancer Center at the University of North Carolina at Chapel Hill have for the first time implicated a growth-promoting cellular protein as one trigger of the inevitable recurrence of advanced prostate cancer in men who are undergoing drug treatment to shut down their sex hormones, or androgens.
Scientists have developed a novel strategy for tackling neurodegenerative diseases such as Huntington’s disease: encouraging an individual’s own cells to “eat” the malformed proteins that lead to the disease.